Portland, OR – Kashi Clinical Laboratories, a leading provider of high complexity clinical diagnostic testing to hospitals, long-term care facilities and transplant centers around the world, is pleased to announce the appointment of Todd Johnson, MD as Chief Executive Officer. Dr. Johnson succeeds Dr. Zahra Kashi, who will continue as Chief Scientific Officer to advance the company’s scientific roadmap and research and development initiatives.
Dr. Johnson brings over 25 years of experience in healthcare, having previously served in executive roles at healthcare market leaders such as McKinsey & Company, MDS/Celerion, AbbVie, and Optum. He has a proven track record of leadership, innovation, and strategic growth, which aligns with Kashi’s mission to provide exceptional clinical diagnostic testing and innovative services to help monitor health and guide treatment for patients throughout our community.
“I am honored to join Kashi Clinical Laboratories and look forward to working with this talented team to provide high-quality laboratory services to patients,” said Dr. Johnson. “Together, we will build on the company’s strong foundation and drive innovation to meet the evolving needs of our customers and the healthcare industry.”
Dr. Zahra Kashi commented, “I am confident that Dr. Johnson is the ideal leader to elevate Kashi to the next level. His extensive experience and commitment to excellence will be invaluable as we continue to expand our capabilities and services.”
Kashi has been a trusted partner in laboratory testing for over 18 years, providing cutting molecular and virology testing. With Dr. Johnson’s appointment as CEO, the company is poised for continued growth.
For more information, please contact:
Dena Balbach
Chief Business Officer
503-206-4989
dbalbach@kashilab.com
www.kashilab.com
